Series D funding round for Revance Therapeutics raising $26M in January 2010
Series D funding round for Revance Therapeutics raising $26M in January 2010
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$284M
Top Valuation
-
Revance Therapeutics raised $26M in a Series D round.
The round was announced on 01/01/10.